Nj State Employees Deferred Compensation Plan Wave Life Sciences Ltd. Transaction History
Nj State Employees Deferred Compensation Plan
- $877 Million
- Q3 2025
A detailed history of Nj State Employees Deferred Compensation Plan transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Nj State Employees Deferred Compensation Plan holds 11,700 shares of WVE stock, worth $86,814. This represents 0.01% of its overall portfolio holdings.
Number of Shares
11,700
Previous 11,700
-0.0%
Holding current value
$86,814
Previous $76,000
10.53%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding WVE
# of Institutions
191Shares Held
135MCall Options Held
495KPut Options Held
36.2K-
Ra Capital Management, L.P. Boston, MA18.2MShares$135 Million2.59% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA15MShares$111 Million0.17% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx8.26MShares$61.3 Million0.92% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$50 Million0.0% of portfolio
-
Driehaus Capital Management LLC Chicago, IL6.53MShares$48.5 Million0.41% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $644M
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...